Precision Control
Dragonflies have long inspired engineers with their ability to independently maneuver each of their four wings, enhancing control in all directions
Excellent Vision
Dragonflies have nearly 360-degree panoramic vision and can perceive a wide spectrum of colors, including ultraviolet and polarized light
Fierce Predators
As adults, these insects capture up to 95 percent of the prey they hunt
Learn More
A New Era in Pancreaticobiliary Care Begins
Innovation With A Purpose
Determined to break through decades of conventional thinking, restricted by standard endoscope design, we have challenged at every turn to deliver a new paradigm in the treatment of pancreaticobiliary disease.
Our first-of-its-kind fully rotatable pancreaticobiliary scope combines refined optics, precision control and advanced therapeutic capabilities without sacrificing external dimensions to deliver meaningful innovation to the field of cholangiopancreatoscopy.
42% Increase
In Working Channel Diameter vs. Current Standard*
**no increase in scope outer diameter
* All product claims are supported by data on file with legal manufacturer and are intended for informational purposes only
Meet the Visionaries Behind Dragonfly
A Team Committed to Transforming Pancreaticobiliary Care
Jeremy Starkweather
Co-Founder & CEO
Jeremy's Brief
- 25 years of experience specializing in technology innovation, assessment, and development, with a strong focus on downstream commercialization and market development
- Managing Director of Phase Therapeutics and Managing Partner at Monarc Partners, with expertise across multiple surgical and interventional specialties
- Led the U.S. launch of the AXIOS™ Stent as VP of Sales & Business Development at Xlumena before its acquisition by Boston Scientific in 2015
Jason Ylizarde
Co-Founder & Vice President, Commercialization
Jason's Brief
- Over 25 years of global medtech experience, including 20 years in the GI space, with leadership roles across Gastroenterology, General Surgery, and Orthopedics
- Played a key role in the commercialization and exits of four venture-backed GI startups—Mauna Kea Technologies, Beacon Endoscopic, Xlumena, and Medigus
- Spent the past seven years founding and investing in transformative GI and Pulmonary technologies
John Wynne
Co-Founder & Vice President, Business Development
John's Brief
- 20 years of experience in medical devices and pharmaceuticals, specializing in business development, strategy, and marketing
- Focused on evaluating early-stage technologies for investment or acquisition, playing a key role in over $1B in acquisitions
- Held various corporate and business unit roles at Boston Scientific, driving strategic growth through early-stage technology investments
Christen Springs
Co-Founder & Vice President, Market Development
Christen's Brief
- Over 20 years of medtech experience, including 15 in executive leadership and founding roles in early-stage medical device startups
- Co-founder of EndoRx and Co-Inventor of the Rhino biliary stone balloon. Acquired by CONMED in 2017
- Co-Founder of DFC Medical and Co-Inventor of the Mammo-Flex breast surgery localization system, which received FDA clearance and launched in the US in 2024
Tony Sullivan
Vice President, Sales & Marketing
Tony's Brief
- 15 years of executive sales and marketing experience in the gastrointestinal space with Boston Scientific and Olympus
- Led commercial efforts for a $494M GI capital and disposables business at Olympus Endoscopy as Executive Director of Marketing, Core GI Solutions
- Spearheaded the launch of Olympus’ first endoscopy imaging platform in over a decade, EVIS X1, achieving over $150M in first-year sales
Recent News
Latest updates from Dragonfly™ Endoscopy Inc.
Dragonfly™ Endoscopy Inc. Hires Industry Veteran As VP of Sales & Marketing
Dragonfly™ Endoscopy Inc. is pleased to announce the appointment of Tony Sullivan as Vice President, Sales & Marketing.
Dragonfly™ Endoscopy Inc. Announces Successful Completion of 1st Procedures
Dragonfly™ Endoscopy Inc. is excited to share the successful completion of the first clinical cases utilizing its advanced Pancreaticobiliary System at the University of Colorado Anschutz Medical Campus.
Dragonfly™ Endoscopy Inc. Announces FDA 510(k) Clearance of Innovative Pancreaticobiliary Scope
Dragonfly™ Endoscopy Inc. is proud to announce FDA 510(k) clearance of a novel 360° Rotatable Pancreaticobiliary Scope.
Contact Info
Dragonfly Endoscopy
9800 Pyramid Ct.
Suite 400,
Englewood, CO 80112
T. 720-303-1360
A New Era in Pancreaticobiliary Care Begins
Contact Us Today
Dragonfly Endoscopy
9800 Pyramid Ct.
Suite 400,
Englewood, CO 80112
T. 720-303-1360
Or use the contact form below.